Hesperetin derivative-16 attenuates CCl4-induced inflammation and liver fibrosis by activating AMPK/SIRT3 pathway
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Hesperetin derivative-16 attenuates CCl4-induced inflammation and liver fibrosis by activating AMPK/SIRT3 pathway
Authors
Keywords
HD-16, Liver fibrosis, Inflammation, SIRT3, AMPK
Journal
EUROPEAN JOURNAL OF PHARMACOLOGY
Volume 915, Issue -, Pages 174530
Publisher
Elsevier BV
Online
2021-12-10
DOI
10.1016/j.ejphar.2021.174530
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Platycodin D alleviates liver fibrosis and activation of hepatic stellate cells by regulating JNK/c-JUN signal pathway
- (2020) Yong-mei Liu et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Epigenetic silencing of LncRNA ANRIL enhances liver fibrosis and HSC activation through activating AMPK pathway
- (2020) Jing‐Jing Yang et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- SIRT1 and aging related signaling pathways
- (2020) Cui Chen et al. MECHANISMS OF AGEING AND DEVELOPMENT
- The Roles of Mitochondrial SIRT4 in Cellular Metabolism
- (2019) Zheying Min et al. Frontiers in Endocrinology
- AMPK agonist AICAR ameliorates portal hypertension and liver cirrhosis via NO pathway in the BDL rat model
- (2019) Liangshuo Hu et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Inflammatory pathways in alcoholic steatohepatitis
- (2019) Bin Gao et al. JOURNAL OF HEPATOLOGY
- Berberine alleviates nonalcoholic fatty liver induced by a high-fat diet in mice by activating SIRT3
- (2019) Xi Xu et al. FASEB JOURNAL
- Downregulation of sirtuin 3 by palmitic acid increases the oxidative stress, impairment of mitochondrial function, and apoptosis in liver cells
- (2019) Garima Sharma et al. JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY
- SIRT1 protects cochlear hair cell and delays age-related hearing loss via autophagy
- (2019) Jiaqi Pang et al. NEUROBIOLOGY OF AGING
- SIRT7 mediates L1 elements transcriptional repression and their association with the nuclear lamina
- (2019) Berta N Vazquez et al. NUCLEIC ACIDS RESEARCH
- SIRT2: Controversy and multiple roles in disease and physiology
- (2019) Yan Wang et al. AGEING RESEARCH REVIEWS
- Wogonin attenuates liver fibrosis via regulating hepatic stellate cell activation and apoptosis
- (2019) Xiao-Sa Du et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Hesperetin derivative attenuates CCl4-induced hepatic fibrosis and inflammation by Gli-1-dependent mechanisms
- (2019) Xin Chen et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Celastrol exerts anti‐inflammatory effect in liver fibrosis via activation of AMPK‐SIRT3 signalling
- (2019) Yuqin Wang et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Low-Level Saturated Fatty Acid Palmitate Benefits Liver Cells by Boosting Mitochondrial Metabolism via CDK1-SIRT3-CPT2 Cascade
- (2019) Lin Liu et al. DEVELOPMENTAL CELL
- Naringenin attenuates the progression of liver fibrosis via inactivation of hepatic stellate cells and profibrogenic pathways
- (2019) Erika Hernández-Aquino et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Dihydromyricetin Ameliorates Nonalcoholic Fatty Liver Disease by Improving Mitochondrial Respiratory Capacity and Redox Homeostasis Through Modulation of SIRT3 Signaling
- (2018) Xianglong Zeng et al. ANTIOXIDANTS & REDOX SIGNALING
- Autophagy inhibition attenuates the induction of anti-inflammatory effect of catalpol in liver fibrosis
- (2018) Zhaoguo Liu et al. BIOMEDICINE & PHARMACOTHERAPY
- Functions of the sirtuin deacylase SIRT5 in normal physiology and pathobiology
- (2018) Surinder Kumar et al. CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Diabetes, plasma glucose and incidence of fatty liver, cirrhosis and liver cancer: A prospective study of 0.5 million people
- (2018) Yuanjie Pang et al. HEPATOLOGY
- Design, synthesis and investigation of potential anti-inflammatory activity of O-alkyl and O-benzyl hesperetin derivatives
- (2018) Ai-Ling Huang et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- SENP2 alleviates CCl 4 -induced liver fibrosis by promoting activated hepatic stellate cell apoptosis and reversion
- (2018) Fang-Tian Bu et al. TOXICOLOGY LETTERS
- Liver fibrosis
- (2018) M. Merve Aydin et al. Turkish Journal of Gastroenterology
- Therapeutic effect of Sirtuin 3 on ameliorating nonalcoholic fatty liver disease: The role of the ERK-CREB pathway and Bnip3-mediated mitophagy
- (2018) Ruibing Li et al. Redox Biology
- Anthocyanins isolated from blueberry ameliorates CCl4 induced liver fibrosis by modulation of oxidative stress, inflammation and stellate cell activation in mice
- (2018) Jianchao Sun et al. FOOD AND CHEMICAL TOXICOLOGY
- γ-Mangostin alleviates liver fibrosis through Sirtuin 3-superoxide-high mobility group box 1 signaling axis
- (2018) Anqi Wang et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Hesperitin derivative-11 suppress hepatic stellate cell activation and proliferation by targeting PTEN/AKT pathway
- (2017) Wan-xia Li et al. TOXICOLOGY
- Hesperetin derivative-14 alleviates inflammation by activating PPAR-γ in mice with CCl 4 -induced acute liver injury and LPS-treated RAW264.7 cells
- (2017) Xin Chen et al. TOXICOLOGY LETTERS
- AMPK: a novel target for treating hepatic fibrosis
- (2017) Zhenxing Liang et al. Oncotarget
- Reversal of liver cirrhosis: current evidence and expectations
- (2017) Young Kul Jung et al. KOREAN JOURNAL OF INTERNAL MEDICINE
- The characteristics of activated portal fibroblasts/myofibroblasts in liver fibrosis
- (2016) Daniel Karin et al. DIFFERENTIATION
- New Developments on the Treatment of Liver Fibrosis
- (2016) Yukinori Koyama et al. DIGESTIVE DISEASES
- Cucurbitacin E ameliorates hepatic fibrosis in vivo and in vitro through activation of AMPK and blocking mTOR-dependent signaling pathway
- (2016) Yan-Ling Wu et al. TOXICOLOGY LETTERS
- Sirtuin regulation in aging and injury
- (2015) Ninu Poulose et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Sirtuins: Nodes Connecting Aging, Metabolism and Tumorigenesis
- (2014) Yisha Yao et al. CURRENT PHARMACEUTICAL DESIGN
- Sirtuins Family- Recent Development as a Drug Target for Aging, Metabolism, and Age Related Diseases
- (2013) Chiranjib Chakraborty et al. CURRENT DRUG TARGETS
- Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B
- (2010) Ting-Tsung Chang et al. HEPATOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now